Press Release – Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic. 0 Replies April 24, 2008 04/24/08 Contine Reading & Discuss→
Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 0 Replies April 07, 2008 Contine Reading & Discuss→
Silence Therapeutics announces Directors share purchases 0 Replies April 01, 2008 Contine Reading & Discuss→
